SKILLMAN, N.J., July 22 /PRNewswire/ -- ConvaTec, a world-leading provider of innovative medical technologies for community and hospital care, today announced the launch of a new web site, www.Hydrofiber.com, demonstrating how the company's proprietary Hydrofiber(R) Technology is transforming wound care.
Designed for clinicians managing chronic and acute wounds, the web site illustrates the unique features and benefits of Hydrofiber(R) Technology with extensive video, data and commentary from research scientists within ConvaTec Wound Therapeutics. This transformational technology, unique to ConvaTec, powers the performance of advanced wound care products, including AQUACEL(R), AQUACEL(R) Ag and Versiva(R) XC(R) dressings, each developed for different wound management needs.
"Hydrofiber(R) Technology is the intelligent choice to meet the diverse wound care needs of clinicians and their individual patients," said Michael Steadman, President of ConvaTec Wound Therapeutics. "This exciting, new online resource shows how our high performance dressings not only help clinicians achieve better outcomes and improve the patient experience, but also contribute to cost control."
Wounds can have a significant impact on the costs of both chronic and acute care. For example, U.S. hospital stays for adults during which pressure ulcers were diagnosed increased by 79% from 1993 to 2006, and the cost of 2006 hospitalizations including a diagnosis of pressure ulcers totaled $11 billion.(1) In addition, surgical site infections have been estimated in an analysis of 2005 National Inpatient Sample data to generate $1.6 billion in excess costs to US hospitals per year.(2)
ConvaTec dressings with Hydrofiber(R) Technology gel on contact with fluid, providing clinicians and patients with substantial wound care benefits. This unique gelling action enables the dressings to lock in exudate and its harmful components(3-5a) and contour closely to the wound bed,(6a) in response to changing wound conditions. With the addition of ionic silver, AQUACEL(R) Ag dressing also provides "on demand" broad-spectrum antimicrobial activity, responding to increased bacterial load with increased silver ion availability.(7,8a,b)
Advanced Wound Dressings with Hydrofiber(R) Technology from ConvaTec
AQUACEL(R) and AQUACEL(R) Ag dressings are soft, absorbent non-woven wound dressings based on Hydrofiber(R) Technology. Indicated for a wide range of moderate-to-highly exuding chronic and acute wounds, AQUACEL(R) and AQUACEL(R) Ag dressings come in a variety of shapes, sizes and formats. AQUACEL(R) Ag dressing also provides the broad-spectrum antimicrobial properties of ionic silver, which kills a broad range of pathogens in the dressing, including MRSA and vancomycin-resistant enterococci (VRE).(7)
Versiva(R) XC(R) dressing provides all the benefits of Hydrofiber(R) Technology plus a waterproof backing that acts as a barrier against bacteria and viral pathogens, including HIV and Hepatitis.(c,d) The unique properties of Versiva(R) XC(R) dressing help progress wounds toward healing.(9,10) Indicated for use with moderately-to-highly exuding chronic and acute wounds, because it includes Hydrofiber(R) Technology, Versiva(R) XC(R) dressing is also the only dressing designed specifically to cover AQUACEL(R) and AQUACEL(R) Ag dressings.
ConvaTec dressings containing Hydrofiber(R) Technology have been evaluated in numerous clinical trials across a range of chronic and acute wounds, including pressure ulcers, leg ulcers, diabetic foot ulcers, partial thickness (second degree) burns and surgical incisions.
ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key business divisions - Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices - ConvaTec products support health care professionals from the hospital to the community health setting. From its headquarters in Skillman, New Jersey, the company oversees more than 8,000 employees in over 90 countries serving consumers and their health care professionals on six continents. For more information, please visit www.convatec.com.
a. As demonstrated in vitro
b. The amount of silver released is controlled by the maximum concentration of silver that can enter solution.
c. provided the dressing remains intact and without leakage. The use of this dressing neither guarantees nor warrantees against AIDS or Hepatitis virus transmission.
d. use waterproof tape to secure the edges of non-adhesive dressing or dressings that have been cut across the central area
Hydrofiber, AQUACEL, Versiva and XC are registered trademarks of ConvaTec Inc.
(C) 2009 ConvaTec Inc.
Contacts: Punnie Donohue ConvaTec Phone: (908) 904-2151 Punnie.Donohue@convatec.com Courtney Judd Weber Shandwick Phone: (212) 445-8365 email@example.com
Copyright©2009 PR Newswire.
All rights reserved